All Title Author
Keywords Abstract

PLOS ONE  2014 

Host Responses to Sepsis Vary in Different Low-Lethality Murine Models

DOI: 10.1371/journal.pone.0094404

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction Animal models for the study of sepsis are being increasingly scrutinized, despite their essential role for early translational research. In particular, recent studies have suggested that at the level of the leukocyte transcriptome, murine models of burns, trauma and endotoxemia markedly differ from their human equivalents, and are only weakly similar amongst themselves. We compared the plasma cytokine and leukocyte transcriptome responses between two different low-lethality murine models of polymicrobial intra-abdominal sepsis. Methods Six to ten week male C57BL/6j mice underwent either the ‘gold standard’ cecal ligation and puncture (CLP) model of intra-abdominal sepsis or administration of a cecal slurry (CS), where cecal contents are injected intraperitoneally. Surviving mice were euthanized at two hours, one or three days after sepsis. Results The murine leukocyte transcriptomic response to the CLP and CS models of sepsis was surprisingly dissimilar at two hours, one, and three days after sepsis. The Pearson correlation coefficient for the maximum change in expression for the entire leukocyte transcriptome that changed significantly over time (n = 19,071) was R = 0.54 (R2 = 0.297). The CS model resulted in greater magnitude of early inflammatory gene expression changes in response to sepsis with associated increased production of inflammatory chemokines and cytokines. Two hours after sepsis, CLP had more significant expression of genes associated with IL-10 signaling pathways, whereas CS had greater expression of genes related to CD28, apoptosis, IL-1 and T-cell receptor signaling. By three days, the changes in gene expression in both sepsis models were returning to baseline in surviving animals. Conclusion These analyses reveal that the murine blood leukocyte response to sepsis is highly dependent on which model of intra-abdominal sepsis is employed, despite their similar lethality. It may be difficult to extrapolate findings from one murine model to another, let alone to human sepsis.

References

[1]  Boomer JS, To K, Chang KC, Takasu O, Osborne DF, et al. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. Jama 306: 2594–2605. doi: 10.1001/jama.2011.1829
[2]  Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, et al. (2005) A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg 140: 432–438 discussion 438–440. doi: 10.1001/archsurg.140.5.432
[3]  Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310. doi: 10.1097/00003246-200107000-00002
[4]  Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, et al. (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323–2329. doi: 10.1001/jama.2009.1754
[5]  Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, et al. (2002) Reducing mortality in sepsis: new directions. Crit Care 6 Suppl 3S1–18. doi: 10.1186/cc1860
[6]  Hotchkiss RS, Opal S (2010) Immunotherapy for sepsis–a new approach against an ancient foe. N Engl J Med 363: 87–89. doi: 10.1056/nejmcibr1004371
[7]  Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, et al. (2012) Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 72: 1491–1501. doi: 10.1097/ta.0b013e318256e000
[8]  Deitch EA (2005) Rodent models of intra-abdominal infection. Shock 24 Suppl 119–23. doi: 10.1097/01.shk.0000191386.18818.0a
[9]  Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507–3512.
[10]  Gentile LF, Nacionales DC, Cuenca AG, Armbruster M, Ungaro RF, et al. (2013) Identification and description of a novel murine model for polytrauma and shock. Crit Care Med 41: 1075–1085. doi: 10.1097/ccm.0b013e318275d1f9
[11]  Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res 29: 189–201. doi: 10.1016/0022-4804(80)90037-2
[12]  Weighardt H, Heidecke CD, Emmanuilidis K, Maier S, Bartels H, et al. (2000) Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery 127: 309–315. doi: 10.1067/msy.2000.104118
[13]  Schwandt T, Schumak B, Gielen GH, Jungerkes F, Schmidbauer P, et al. (2012) Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J 31: 201–213. doi: 10.1038/emboj.2011.380
[14]  Wynn JL, Scumpia PO, Delano MJ, O’Malley KA, Ungaro R, et al. (2007) Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28: 675–683. doi: 10.1097/shk.0b013e3180556d09
[15]  Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moldawer LL, Efron PA (2010) Cecal ligation and puncture. Curr Protoc Immunol Chapter 19: Unit 19 13.
[16]  Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032–1037. doi: 10.1038/nature03985
[17]  Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, et al. (2009) A genomic score prognostic of outcome in trauma patients. Mol Med 15: 220–227.
[18]  Cuenca AG, Gentile LF, Lopez MC, Ungaro R, Liu H, et al. (2013) Development of a Genomic Metric That Can Be Rapidly Used to Predict Clinical Outcome in Severely Injured Trauma Patients. Crit Care Med.
[19]  Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, et al. (2005) Preclinical models of shock and sepsis: what can they tell us? Shock 24 Suppl 11–6. doi: 10.1097/01.shk.0000191383.34066.4b
[20]  Dyson A, Singer M (2009) Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37: S30–37. doi: 10.1097/ccm.0b013e3181922bd3
[21]  Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854–865. doi: 10.1038/nrd1854
[22]  Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731–2738. doi: 10.4049/jimmunol.172.5.2731
[23]  Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13: 110–116. doi: 10.1097/00024382-200013020-00004
[24]  Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, et al. (1995) Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4: 89–95. doi: 10.1097/00024382-199508000-00002
[25]  Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, et al. (2011) A genomic storm in critically injured humans. J Exp Med 208: 2581–2590. doi: 10.1084/jem.20111354
[26]  Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49: 186–196. doi: 10.1016/0022-4804(90)90260-9
[27]  Kazarian KK, Perdue PW, Lynch W, Dziki A, Nevola J, et al. (1994) Porcine peritoneal sepsis: modeling for clinical relevance. Shock 1: 201–212. doi: 10.1097/00024382-199403000-00008
[28]  Lang CH, Bagby GJ, Bornside GH, Vial LJ, Spitzer JJ (1983) Sustained hypermetabolic sepsis in rats: characterization of the model. J Surg Res 35: 201–210. doi: 10.1016/s0022-4804(83)80005-5
[29]  Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL (1978) A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg 113: 853–857. doi: 10.1001/archsurg.1978.01370190075013
[30]  Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, et al. (2011) A genomic storm in critically injured humans. J Exp Med 208: 2581–2590. doi: 10.1084/jem.20111354
[31]  Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15: 496–497. doi: 10.1038/nm0509-496
[32]  Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138–150. doi: 10.1056/nejmra021333
[33]  Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125–1128. doi: 10.1097/00003246-199607000-00010
[34]  Gentile LF, Nacionales DC, Lopez CM, Vanzant E, Cuenca A, et al. (2014) A Better Understanding of Why Murine Models of Trauma Do Not Recapitulate the Human Syndrome. Crit Care Med in press.
[35]  Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, et al. (2014) Protective Immunity and Defects in the Neonatal and Elderly Immune Response to Sepsis. J Immunol.

Full-Text

comments powered by Disqus